Journal of Hematology & Oncology,
Год журнала:
2024,
Номер
17(1)
Опубликована: Март 22, 2024
Abstract
Inflammation
has
accompanied
human
beings
since
the
emergence
of
wounds
and
infections.
In
past
decades,
numerous
efforts
have
been
undertaken
to
explore
potential
role
inflammation
in
cancer,
from
tumor
development,
invasion,
metastasis
resistance
tumors
treatment.
Inflammation-targeted
agents
not
only
demonstrate
suppress
cancer
but
also
improve
efficacy
other
therapeutic
modalities.
this
review,
we
describe
highly
dynamic
complex
inflammatory
microenvironment,
with
discussion
on
key
mediators
including
cells,
cytokines,
their
downstream
intracellular
pathways.
addition,
especially
address
development
highlight
action
mechanisms
inflammation-targeted
therapies
antitumor
response.
Finally,
summarize
results
both
preclinical
clinical
studies
up
date
illustrate
translation
therapies.
Abstract
Hepatocellular
carcinoma
(HCC)
commonly
emerges
in
an
immunologically
“cold”
state,
thereafter
protects
it
away
from
cytolytic
attack
by
tumor‐infiltrating
lymphocytes,
resulting
poor
response
to
immunotherapy.
Herein,
acidic/photo‐sensitive
dendritic
cell
(DCs)‐based
neoantigen
nano‐vaccine
has
been
explored
convert
tumor
immune
state
into
“hot”,
and
remodel
tumor‐associated
neutrophils
potentiate
anticancer
for
enhancing
immunotherapy
efficiency.
The
is
constructed
SiPCCl
2
‐hybridized
mesoporous
silica
with
coordination
of
Fe(III)‐captopril,
coating
exfoliated
membrane
matured
DCs
H22‐specific
stimulation.
nano‐vaccines
actively
target
H22
tumors
induce
immunological
death
boost
antigen
release
the
generation
excess
1
O
through
photodynamic
therapy,
which
act
as
situ
vaccination
strengthen
antitumor
T‐cell
against
primary
growth.
Interestingly,
are
also
home
lymph
nodes
directly
activation
proliferation
neoantigen‐specific
T
cells
suppress
primary/distal
Moreover,
acidic‐triggered
captopril
microenvironment
can
polarize
protumoral
N2
phenotype
N1
improving
effects
achieve
complete
regression
(83%)
H22‐bearing
mice
prolong
survival
time.
This
work
provides
alternative
approach
developing
novel
HCC
strategies.
International Journal of Nanomedicine,
Год журнала:
2022,
Номер
Volume 17, С. 6427 - 6446
Опубликована: Дек. 1, 2022
Photoactivation
therapy
based
on
photodynamic
(PDT)
and
photothermal
(PTT)
has
been
identified
as
a
tumour
ablation
modality
for
numerous
cancer
indications,
with
photosensitisers
conversion
agents
playing
important
roles
in
the
phototherapy
process,
especially
recent
decades.In
addition,
iteration
of
nanotechnology
strongly
promoted
development
treatment.PDT
can
increase
sensitivity
cells
to
PTT
by
interfering
microenvironment,
whereas
heat
generated
blood
flow,
improve
oxygen
supply
enhance
PDT
therapeutic
effect.In
cell
debris
serve
tumour-associated
antigens,
evoking
antitumor
immune
responses.In
this
review,
research
progress
phototherapy,
its
effects
combination
immunotherapy
treatment
tumours
are
mainly
outlined,
issues
that
may
need
continued
attention
future
raised.
ACS Nano,
Год журнала:
2022,
Номер
16(6), С. 9240 - 9253
Опубликована: Июнь 17, 2022
A
therapeutic
tumor
vaccine
is
a
promising
approach
to
cancer
treatment.
One
of
its
strategies
treat
patient-derived
cells
in
vitro
and
then
administer
them
vivo
induce
an
adaptive
immune
response
achieve
Here,
we
want
explore
the
possibility
converting
tissue
into
through
induced
immunogenic
cell
death
(ICD)
situ.
We
loaded
indocyanine
green
(ICG)
liposomes
(ICG-Lipo)
modified
it
with
pardaxin
peptide
realize
endoplasmic
reticulum
(ER)-targeting
function
(Par-ICG-Lipo).
microfluidic
technique
was
developed
for
loading
ICG,
water-soluble
molecule,
high
encapsulation
efficiency
(greater
than
90%).
Under
near-infrared
(NIR)
irradiation,
ER-targeting
photodynamic
therapy
(PDT)
by
Par-ICG-Lipo
could
promote
release
danger-signaling
molecules
(DAMPs)
antigens
(TAAs)
vivo,
which
significantly
enhanced
immunogenicity
thus
stimulates
strong
antitumor
response.
This
process
would
be
further
amplified
adopting
dendritic
cells.
In
general,
our
strategy
transformed
situ
vaccines
PDT,
provide
clinically
applicable
effective
Bioactive Materials,
Год журнала:
2022,
Номер
21, С. 358 - 380
Опубликована: Сен. 14, 2022
Nanomedicines
for
drug
delivery
and
imaging-guided
cancer
therapy
is
a
rapidly
growing
research
area.
The
unique
properties
of
nanomedicines
have
massive
potential
in
solving
longstanding
challenges
existing
drugs,
such
as
poor
localization
at
the
tumor
site,
high
doses
toxicity,
recurrence,
immune
response.
However,
inadequate
biocompatibility
restricts
their
clinical
translation.
Therefore,
advanced
nanomaterials
with
enhanced
therapeutic
efficiency
are
highly
desired
to
fast-track
translation
nanomedicines.
Intrinsic
nanoscale
covalent
organic
frameworks
(nCOFs),
suitable
size,
modular
pore
geometry
porosity,
straightforward
post-synthetic
modification
via
simple
transformations,
make
them
incredibly
attractive
future
ability
COFs
disintegrate
slightly
acidic
microenvironment
also
gives
competitive
advantage
targeted
delivery.
This
review
summarizes
recently
published
applications
delivery,
photo-immuno
therapy,
sonodynamic
photothermal
chemotherapy,
pyroptosis,
combination
therapy.
Herein
we
mainly
focused
on
modifications
enhance
biocompatibility,
efficacy
will
provide
fundamental
knowledge
designing
biocompatible
nCOFs-based
help
rapid
development
carriers
theranostics.
Angewandte Chemie International Edition,
Год журнала:
2022,
Номер
61(40)
Опубликована: Авг. 2, 2022
Abstract
Herein,
we
report
an
activatable
near‐infrared
(NIR)
afterglow
theranostic
prodrug
that
circumvents
high
background
noise
interference
caused
by
external
light
excitation.
The
can
release
hydroxycamptothecin
(HCPT)
in
response
to
the
intratumoral
peroxynitrite
level
associated
with
immunogenic
cell
death
(ICD),
and
synchronously
activate
signal
monitor
drug
process
cold‐to‐hot
tumor
transformation.
itself
is
ICD
inducer
achieved
photodynamic
therapy
(PDT).
PDT
initiates
recruits
first‐arrived
neutrophils
secrete
trigger
HCPT
release.
Intriguingly,
demonstrate
significantly
amplify
PDT‐mediated
process.
thus
shows
a
self‐sustainable
magnification
effect
establishing
“ICD‐HCPT
release‐amplified
ICD”
cycling
loop.
In
vivo
studies
eradicate
existing
tumors
prevent
further
recurrence
through
antitumor
immune
response.
Chemical Science,
Год журнала:
2023,
Номер
14(6), С. 1461 - 1471
Опубликована: Янв. 1, 2023
Conventional
photodynamic
therapy
mainly
causes
a
therapeutic
effect
on
the
primary
tumor
through
localized
generation
of
reactive
oxygen
species,
while
metastatic
tumors
remain
poorly
affected.
Complementary
immunotherapy
is
effective
in
eliminating
small,
non-localized
distributed
across
multiple
organs.
Here,
we
report
Ir(iii)
complex
Ir-pbt-Bpa
as
highly
potent
immunogenic
cell
death
inducing
photosensitizer
for
two-photon
against
melanoma.
can
produce
singlet
and
superoxide
anion
radicals
upon
light
irradiation,
causing
by
combination
ferroptosis
death.
In
mouse
model
with
two
physically
separated
melanoma
tumors,
although
only
one
was
irradiated,
strong
reduction
both
observed.
Upon
not
induced
immune
response
CD8
Coordination Chemistry Reviews,
Год журнала:
2023,
Номер
495, С. 215350 - 215350
Опубликована: Авг. 19, 2023
Innovative
anticancer
therapies
based
on
the
activation
of
immune
system
offer
promise
in
battle
against
cancers
resistant
to
traditional
treatments.
Examples
such
therapeutic
approaches
include,
along
with
various
types
immunotherapies,
photodynamic
therapy
(PDT).
PDT
is
a
photochemistry-based
strategy
that
results
not
only
from
its
direct
effects
cancer
cells
but
also
disruption
tumor
vasculature
and
host
system.
However,
achieve
success
manifested
eradication
primary
distant
metastases,
it
necessary
design
suitable
photosensitizers
(PSs)
desired
optical
photophysical
properties
enable
efficient
generation
ROS
under
microenvironmental
(TME)
conditions,
especially
hypoxia.
Thus,
this
review
particular
attention
paid
photochemical
PSs,
notably
sufficiently
long-lived
triplet
states
mechanisms
energy/electron
transfer
reactions.
Photogenerated
initiate
inflammatory
reaction,
expression
heat-shock
proteins,
infiltration
long-term
memory.
These
unique
features
give
new
possibilities
combine
agents
stimulating
response
as
well
immunotherapy,
PD-1/PD-L1
blockade.
Most
systems
explored
aspect
so
far
are
either
derivatives
naturally
occurring
metal
complexes
(Heme,
Chlorophyll
a,
Bacteiochorophyll
-
inspired
PSs),
synthetic
(metallo)porphyrins,
(metallo)phthalocyanines
or
hybrid
materials
containing
nanoparticles.
This
work
summarizes
recent
reports
synthesis
antibody-PS
conjugates
spectroscopic
enhanced
selectivity
biological
activity.
Finally,
most
notable
drawbacks
presented,
scenario
outlined
for
development
alone,
combined
immunotherapy
overcome
these
challenges
future.
Abstract
Phototherapy,
mainly
including
photothermal
therapy
(PTT)
and
photodynamic
(PDT),
can
kill
cancer
cells
by
generating
heat
or
reactive
oxygen
species,
which
has
the
advantages
of
being
minimally
invasive,
high
efficiency,
low
toxicity.
However,
traditional
phototherapeutic
agents
face
challenges
such
as
poor
tumor
targeting,
susceptibility
to
passive
immune
clearance,
suboptimal
biocompatibility,
limit
their
clinical
application.
Recently,
cell
membrane
biomimetic
technology
endows
with
unique
biological
functions,
promoted
escape,
prolonged
in
vivo
circulation
time,
improved
enhanced
anti‐tumor
efficacy.
In
addition,
phototherapy
mediated
(CCM)
membrane‐modified
promote
broad
immunity.
this
review,
we
deeply
analyze
mechanisms
PTT
PDT,
systematically
discuss
synthesis
strategies
functions
nanomaterials,
focus
on
progress
based
nanomaterials
synergistic
therapies
chemotherapy,
radiotherapy,
immunotherapy,
sonodynamic
therapy.
Finally,
address
opportunities
future
prospects
field
phototherapy.
This
comprehensive
review
is
expected
provide
insights
into
promoting
translation
agents.
Asian Journal of Pharmaceutical Sciences,
Год журнала:
2023,
Номер
18(1), С. 100775 - 100775
Опубликована: Янв. 1, 2023
Photodynamic
therapy
(PDT)
is
applied
as
a
robust
therapeutic
option
for
tumor,
which
exhibits
some
advantages
of
unique
selectivity
and
irreversible
damage
to
tumor
cells.
Among
which,
photosensitizer
(PS),
appropriate
laser
irradiation
oxygen
(O2)
are
three
essential
components
PDT,
but
the
hypoxic
microenvironment
(TME)
restricts
O2
supply
in
tissues.
Even
worse,
metastasis
drug
resistance
frequently
happen
under
condition,
further
deteriorate
antitumor
effect
PDT.
To
enhance
PDT
efficiency,
critical
attention
has
been
received
by
relieving
hypoxia,
innovative
strategies
on
this
topic
continue
emerge.
Traditionally,
supplement
strategy
considered
direct
effective
relieve
TME,
whereas
it
confronted
with
great
challenges
continuous
supply.
Recently,
O2-independent
provides
brand
new
can
avoid
influence
TME.
In
addition,
synergize
other
strategies,
such
chemotherapy,
immunotherapy,
photothermal
(PTT)
starvation
therapy,
remedy
inadequate
hypoxia
conditions.
paper,
we
summarized
latest
progresses
development
improve
efficacy
against
were
classified
into
O2-dependent
synergistic
therapy.
Furthermore,
deficiencies
various
also
discussed
envisage
prospects
future
study.